Development of inflammatory bowel disease (IBD) following the use of biologic treatment for rheumatologic diseases: A review of the Food and Drug Administration Adverse Event Reports System (FAERS)
Recommended Citation
Hashmi S, Hoff R, Ehrenpreis E. Development of inflammatory bowel disease (IBD) following the use of biologic treatment for rheumatologic diseases: A review of the Food and Drug Administration Adverse Event Reports System (FAERS). Gastroenterology. 2020; 158(6, supplement 1):S959-S960. doi: 10.1016/S0016-5085(20)33076-6
Presentation Notes
Accepted for presentation at Digestive Disease Week, The Brightest Ideas & Breakthroughs in Digestive Health. May 2-5, 2020; canceled due to COVID-19.
Document Type
Abstract
